Mairs & Power Inc’s Novartis NVS Stock Holding History

Mairs & Power Inc’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,485	Closed	-$205K	–	254
2025 Q4	$205K	Buy	+1,485	New	+$194K	﹤0.01%	237
2025 Q3	–	Sell	-1,795	Closed	-$217K	–	256
2025 Q2	$217K	Buy	+1,795	New	+$202K	﹤0.01%	223
2024 Q1	–	Sell	-2,024	Closed	-$204K	–	232
2023 Q4	$204K	Buy	+2,024	New	+$195K	﹤0.01%	220
2023 Q2	–	Sell	-2,280	Closed	-$210K	–	240
2023 Q1	$210K	Hold	2,280	–	–	﹤0.01%	222
2022 Q4	$207K	Buy	+2,280	New	+$192K	﹤0.01%	216
2022 Q2	–	Sell	-2,309	Closed	-$203K	–	211
2022 Q1	$203K	Sell	2,309 -227	-9%	-$19.7K	﹤0.01%	213
2021 Q4	$222K	Buy	+2,536	New	+$211K	﹤0.01%	207
2021 Q3	–	Sell	-2,530	Closed	-$231K	–	213
2021 Q2	$231K	Hold	2,530	–	–	﹤0.01%	201
2021 Q1	$216K	Sell	2,530 -170	-6%	-$15.3K	﹤0.01%	208
2020 Q4	$255K	Sell	2,700 -130	-5%	-$11.4K	﹤0.01%	197
2020 Q3	$246K	Sell	2,830 -200	-7%	-$17.3K	﹤0.01%	188
2020 Q2	$265K	Hold	3,030	–	–	﹤0.01%	186
2020 Q1	$250K	Buy	3,030 +130	+4%	+$11.6K	﹤0.01%	183
2019 Q4	$275K	Hold	2,900	–	–	﹤0.01%	190
2019 Q3	$252K	Hold	2,900	–	–	﹤0.01%	185
2019 Q2	$265K	Sell	2,900 -336	-10%	-$28.4K	﹤0.01%	185
2019 Q1	$279K	Hold	3,236	–	–	﹤0.01%	182
2018 Q4	$249K	Sell	3,236 -335	-9%	-$26.1K	﹤0.01%	186
2018 Q3	$276K	Hold	3,571	–	–	﹤0.01%	187
2018 Q2	$242K	Sell	3,571 -56	-2%	-$3.86K	﹤0.01%	192
2018 Q1	$263K	Sell	3,627 -558	-13%	-$42.5K	﹤0.01%	184
2017 Q4	$315K	Hold	4,185	–	–	﹤0.01%	171
2017 Q3	$322K	Sell	4,185 -558	-12%	-$42.1K	﹤0.01%	167
2017 Q2	$355K	Sell	4,743 -1,835	-28%	-$130K	﹤0.01%	158
2017 Q1	$438K	Sell	6,578 -177	-3%	-$11.8K	0.01%	150
2016 Q4	$441K	Sell	6,755 -336	-5%	-$21.8K	0.01%	146
2016 Q3	$502K	Buy	7,091 +2,873	+68%	+$209K	0.01%	140
2016 Q2	$312K	Hold	4,218	–	–	﹤0.01%	152
2016 Q1	$274K	Sell	4,218 -335	-7%	-$22.8K	﹤0.01%	163
2015 Q4	$351K	Hold	4,553	–	–	0.01%	148
2015 Q3	$375K	Hold	4,553	–	–	0.01%	141
2015 Q2	$401K	Hold	4,553	–	–	0.01%	140
2015 Q1	$402K	Sell	4,553 -223	-5%	-$19.8K	0.01%	149
2014 Q4	$397K	Sell	4,776 -57	-1%	-$4.72K	0.01%	153
2014 Q3	$408K	Buy	4,833 +252	+6%	+$20.4K	0.01%	149
2014 Q2	$372K	Hold	4,581	–	–	0.01%	153
2014 Q1	$349K	Buy	4,581 +614	+15%	+$44.7K	0.01%	157
2013 Q4	$286K	Sell	3,967 -301	-7%	-$20.9K	﹤0.01%	187
2013 Q3	$293K	Sell	4,268 -523	-11%	-$34.6K	0.01%	151
2013 Q2	$304K	Buy	+4,791	New	+$312K	0.01%	148

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Mairs & Power Inc's NVS Position: Q1 2026 in Review

Mairs & Power Inc sold out of Novartis (NVS) in Q1 2026, closing a stake of 1,485 shares — an estimated $205K sold.

Mairs & Power Inc first reported a position in NVS in Q2 2013 and held it in 40 quarters. The position peaked at $502K in Q3 2016. 1,599 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

Mairs & Power Inc reported no remaining Novartis position as of Q1 2026 after selling out during the quarter.
Mairs & Power Inc sold 1,485 Novartis shares in Q1 2026, an estimated $205K.
Mairs & Power Inc first reported a position in Novartis in Q2 2013 and held it in 40 quarters.
Mairs & Power Inc's Novartis position peaked at $502K in Q3 2016.
1,599 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Mairs & Power Inc's 13F filing for Q1 2026, filed 14 May 2026.